title: Attention to Infliximab adverse events: chimeric monoclonal antibodies can induce anti chimeric antibodies that may result in Kounis hypersensitivity associated acute coronary syndrome.
authors.affiliation: Department of Medical Sciences, Northwestern Greece Highest Institute of Education and Technology, Patras, Achaia, Greece. ngkounis@otenet.gr.
authors.forename: N G
authors.initials: NG
authors.lastname: Kounis
authors.forename: G N
authors.initials: GN
authors.lastname: Kounis
authors.forename: G D
authors.initials: GD
authors.lastname: Soufras
authors.forename: G
authors.initials: G
authors.lastname: Tsigkas
authors.forename: G
authors.initials: G
authors.lastname: Hahalis
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D005765:Gastrointestinal Agents / Q000009:adverse effects*; D006801:Humans; D008297:Male
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents